Antonio Ottobrelli Selected Research

Antonio Ottobrelli Research Topics

2	Hepatitis C 01/2017 - 08/2002
2	Fibrosis (Cirrhosis) 01/2017 - 09/2003
1	Acute-On-Chronic Liver Failure 01/2022
1	COVID-19 05/2021
1	Vascular Remodeling 01/2019
1	Liver Diseases (Liver Disease) 09/2017
1	Hepatic Encephalopathy 09/2017
1	Splenomegaly 07/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2006
1	End Stage Liver Disease 07/2006
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2005
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2005
1	Aseptic Meningitis 03/2005
1	Ulcerative Colitis 03/2005
1	Lung Injury 03/2005
1	Hepatocellular Carcinoma (Hepatoma) 09/2003
1	Hepatitis 08/2002
1	Leukopenia 08/2002
1	Anemia 08/2002

2	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 08/2002
1	BilirubinIBA 09/2017
1	CreatinineIBA 09/2017
1	SofosbuvirIBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2006
1	Alemtuzumab (Campath)FDA Link 09/2005
1	Mesalamine (Mesalazine)FDA LinkGeneric 03/2005
1	CD34 Antigens (CD34 Antigen)IBA 09/2003
1	AntibodiesIBA 09/2003
1	InterferonsIBA 08/2002
1	Interferon alpha-2 (Roferon-A)FDA Link 08/2002

5	Liver Transplantation 01/2022 - 08/2002
2	Therapeutics 01/2017 - 08/2002
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 09/2017
1	Transjugular Intrahepatic Portasystemic Shunt 09/2017
1	Aftercare (After-Treatment) 01/2017